Lymphoblastic lymphomas are neoplasms of immature or precursor lymphoid cells with no or limited bone marrow involvement, whose clinical presentation varies according to the immunophenotype. While mediastinal involvement is predominant in T-lymphoblastic lymphomas, B-lymphoblastic lymphomas frequently involve nodal sites. Extranodal presentation of B-lymphoblastic lymphomas is extremely rare. We present the case of a 49-year-old man with B-lymphoblastic lymphoma of the hard palate. The patient was treated with the R-Hyper CVAD regimen and is on maintenance chemotherapy. This is the first reported case of B-lymphoblastic lymphoma arising in the hard palate. L ymphoblastic lymphoma (LBL) is a rare aggressive neoplasm of T-cell or B-cell precursors resembling acute lymphoblastic leukemia, with no or limited bone marrow involvement, that develops more frequently in children and young adults. Lymphoblastic lymphoma of the B-cell type is uncommon, and extranodal presentation is even rarer. We report what is, to the best of our knowledge, the fi rst reported case of B-lymphoblastic lymphoma (B-LBL) of the hard palate.
CASE REPORT
A 49-year-old man presented with pain and swelling in the hard palate for 3 months. Examination of the oral cavity showed diff use, soft, nontender swelling in the hard palate (Figure 1a) . Th ere was no pallor, lymphadenopathy, or organomegaly. Computed tomography scan of the head revealed irregular rarefaction of the anterior aspect of the hard palate. An incisional biopsy of the lesion disclosed subepithelium diff usely infi ltrated with a monotonous population of medium to large cells with vesicular nuclei, prominent nucleoli, and scanty cytoplasm (Figure 2 ). On immunohistochemistry, the cells were positive for CD20, CD34, Bcl2, and Tdt with an MIB labeling index of about 90%. Th e picture was diagnostic of B-LBL. His hemoglobin was 15 g/dL; platelets, 3.5 lakhs/mm 3 ; and total leucocyte count, 7300/mm 3 . Lactate dehydrogenase was 540 U/L. His cerebrospinal fl uid and bone marrow studies were normal. Computed tomography scans of the neck, thorax, abdomen, and pelvis were normal, and he was staged as stage 1. Th e patient was started on rituximab, cyclophosphamide, vincristine, doxorubicin, and dexamethasone (R-Hyper CVAD protocol). After completion of the fi rst cycle of chemotherapy, his symptoms subsided and the lesions showed signifi cant clinical and radiological regression (Figure 1b ). At present, he is on maintenance chemotherapy.
DISCUSSION
LBL is a highly aggressive neoplasm of lymphoblasts that may be of either T-cell origin (T-LBL) or B-cell origin. Lymphoblastic lymphoma accounts for approximately 2% of all non-Hodgkin lymphomas, out of which T-LBL constitutes around 90% of cases (1) . LBLs are grouped together with acute lymphoblastic leukemia in the 2008 World Health Organization classification of hematopoietic malignancies (2) . Th ese two entities are biologically very close but not identical; in LBL, the bone marrow is not involved or is only partially involved, with less than 20% infi ltrating blast cells. LBL occurs commonly in children, mostly males. T-LBL usually presents with a mediastinal mass, central nervous system involvement, and pleural and pericardial eff usion, whereas B-LBL presentation is more limited than that of T-LBL and the localized disease usually involves single nodal or extranodal sites such as skin, bone, and soft tissue (3, 4) .
Lymphoid lesions of the palate can be either lymphomatous or benign lymphoid hyperplasia. Oral lymphomas are relatively rare and constitute about 4% of all oral malignancies (5) . Th e oral cavity is the primary site of approximately 2% of all extranodal lymphomas (6) . Lymphomas can aff ect both bony and soft tissue of the oral cavity, with the most frequent localization being the tonsil. Th e most common type is diff use large B-cell lymphoma, but mantle cell lymphoma, marginal zone B-cell lymphoma, Burkitt's lymphoma, lymphomablastic lymphoma, peripheral T-cell lymphoma, and anaplastic large cell lymphoma have also been reported in the oral cavity (7). However, B-LBL arising from the hard palate has not been reported previously.
Clinical manifestations depend on the location of the lesion. Th e most common clinical appearance of non-Hodgkin lymphoma in the mouth is a nonhealing, painless ulceration (8) . Patients may complain of localized or diff use soft tissue swelling, pain, mucosal discoloration, paresthesias, anesthesia, and loosening of teeth (9) .
Lymphoblastic lymphomas are treated similar to acute lymphoblastic leukemia with combination chemotherapy protocols consisting of intensive remission-induction chemotherapy, central nervous system prophylaxis, a consolidation chemotherapy, and subsequent maintenance therapy. Treatment of LBL with protocols derived from acute lymphoblastic leukemia therapy are eff ective, with an 82% event-free survival and an 85% overall survival at 5 years (10).
